Oncomine Again Key to Prostate Cancer Discovery
Dan Rhodes, alumni of the Bioinformatics Graduate Program and his company, Compendia Biosciences Inc., make the news for discovering and identifying a gene, called SPINK1, as a key new therapeutic target and biomarker for prostate cancer. More on this story here.


